Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1863-2025

GM Helix Acqua Implant, Article Number: 140.985 Recall

GM Helix Acqua Implant, Article Number: 140.985

FDA recall Class II

Ongoing

FDA lists this Class II recall for GM Helix Acqua Implant, Article Number: 140.985. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1863-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 1, 2025
FDA report date
Jun 4, 2025
Quantity in commerce
207 units (54 US, 153 OUS)
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

GM Helix Acqua Implant, Article Number: 140.985

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

Article Number: 140.985; UDI-DI: (01)7899878024569(11)220125(17)270124(10)JPZ75; Lot number: JPZ75;

View the original FDA recall notice

Why was this product recalled?

It is possible that a package labelled as an 11.5 mm implant may contain a 13 mm implant instead.

What actions did Straumann USA LLC take?

On May 1, 2025 URGENT FIELD SAFETY ACTION letters were sent to customers. Action to be taken: 1. If article 140.984 Lot JPZ21 or 109.985 Lot JPZ75 are still in your inventory, then stop use/distribution of the product immediately and quarantine/segregate physically. 2. If the product was used and no complications or problems were identified, of the patient did not present symptoms there is no need for any additional action with the patient. 3. If article 140.984 Lot JPZ21 or 109.985 Lot JPZ75 are still in your inventory, return it for a credit or replacement as indicated on the Customer Confirmation Form. 4. In the product is not found in your stock, indicate this on the enclosed Customer Confirmation Form. 5 In all cases, complete and return the enclosed Customer Confirmation Form with the affected product using the return UPS label provided to: Straumann USA, LLC; 60 Minuteman Road, Andover, MA 01810. Transmission of the Field Safety Notice: This notice needs to be passed on to all those who need to be aware within your organization or to any organization where the affected devices have been transferred. The FDA has been informed about this Field Safety Corrective Action. We apologize for any inconvenience that this may cause.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology